seed
Stage
1
Investors
About
Macuject provides an AI-enabled clinical decision support SaaS platform aimed at the early detection, monitoring, and treatment guidance for age-related macular degeneration (AMD). The software analyzes clinical data to assist ophthalmic clinicians in identifying and managing AMD progression.
Explore Macuject's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.